Seah Lim, MD, PhD
Chief Executive Officer
Professional Overview
Seah Lim is a seasoned healthcare executive and medical professional with extensive experience spanning the pharmaceutical, biotechnology, and academic sectors. As the Chief Executive Officer of Medicovestor, Inc. and a Corporate Business and Scientific Advisor at Genie Therapeutics, he leverages his deep expertise in clinical research, product development, and strategic leadership to drive innovation and growth in the life sciences industry.
Experience Summary
Current Roles
- Chief Executive Officer, Medicovestor, Inc. (2023-08-01 to Present): Providing strategic direction and operational oversight to advance the company's mission of developing cutting-edge medical technologies. Key responsibilities include spearheading product development, securing funding, and fostering strategic partnerships.
- Corporate Business and Scientific Advisor, Genie Therapeutics (2023-12-01 to Present): Serving as a subject matter expert and strategic consultant, advising the company on scientific and business matters to support the development of novel gene therapy solutions.
- Independent Director, Board of Directors, Emmaus Medical, Inc. (2022-09-01 to Present): Providing governance, strategic guidance, and oversight to the company as it navigates the complex landscape of the pharmaceutical industry.
Career Progression
Seah Lim's distinguished career includes senior leadership roles at several prominent healthcare organizations. Prior to his current positions, he served as the Pediatric Lead and Clinical Research Director in Oncology (Global) at Sanofi, where he spearheaded the development and implementation of innovative clinical trial programs. He has also held the role of Chief Executive Officer and Chief Medical Officer at Biocosm Inc., driving the company's growth and strategic initiatives.
Lim's academic background includes serving as the Chief of the Division of Hematology at New York Medical College, the Director of the Section of Hematology at The Warren Alpert Medical School of Brown University, and the Medical Director of the Hematologic Malignancy Clinical Trials at UPMC. Throughout his career, he has demonstrated a strong commitment to advancing the field of hematology and oncology through his research, clinical expertise, and leadership.
Academic Background
Seah Lim holds a Doctor of Medicine (MD) degree and a Doctor of Philosophy (PhD) in Hematology and Oncology, showcasing his deep understanding of the medical and scientific aspects of the industry. His academic achievements and specialized training have been instrumental in positioning him as a recognized leader in the healthcare sector.
Areas of Expertise
- Clinical research and trial design
- Oncology and hematology drug development
- Regulatory compliance and market access
- Strategic planning and business development
- Cross-functional team leadership and collaboration
Professional Impact
Seah Lim has made significant contributions to the healthcare industry, including leading the successful development and commercialization of several innovative medical products. He has been recognized for his ability to navigate complex regulatory environments, foster productive partnerships, and drive organizational growth. Lim's deep technical expertise, coupled with his strategic vision and business acumen, have positioned him as a respected leader in the life sciences industry.
Conclusion
With his impressive track record of achievements, Seah Lim is poised to continue making a meaningful impact in the healthcare sector. As he advances in his current roles, he remains dedicated to leveraging his extensive experience and expertise to drive innovation, enhance patient outcomes, and shape the future of the industry.
